Clinical Trial Update: Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation

View source ↗

Summary

This update reports responses to chemotherapy in patients with non-small cell lung cancer who harbor a known somatic activating HER2 mutation. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Lung Cancer | Status: COMPLETED